Conatus Pharmaceuticals - Stock Price History | HSTO

Historical daily share price chart and data for Conatus Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Conatus Pharmaceuticals as of September 25, 2020 is 1.45.
  • The all-time high Conatus Pharmaceuticals stock closing price was 142.50 on January 10, 2014.
  • The Conatus Pharmaceuticals 52-week high stock price is 7.50, which is 417.2% above the current share price.
  • The Conatus Pharmaceuticals 52-week low stock price is 1.30, which is 10.3% below the current share price.
  • The average Conatus Pharmaceuticals stock price for the last 52 weeks is 3.52.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Conatus Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 8.7688 18.1000 29.1000 2.6010 4.0000 -76.88%
2018 45.3321 47.5000 75.0000 11.7000 17.3000 -62.55%
2017 53.0614 53.9000 87.7000 39.2000 46.2000 -12.33%
2016 21.7490 29.3000 61.1000 15.0000 52.7000 82.99%
2015 50.4743 80.9000 106.3000 25.9000 28.8000 -58.86%
2014 78.5893 62.6000 142.5000 53.2000 70.0000 8.53%
2013 85.4068 95.0000 104.9000 59.6000 64.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.018B $0.022B
Histogen Inc. is a regenerative medicine company. It engages in developing patented technologies which replace and regenerates tissues in the body. The company's technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products. Histogen Inc., formerly known as Conatus Pharmaceuticals Inc., is based in San Diego, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $183.161B 34.37
Medtronic (MDT) Ireland $138.669B 26.12
Stryker (SYK) United States $76.844B 29.80
Boston Scientific (BSX) United States $53.421B 30.86
Lonza Group Ag (LZAGY) Switzerland $45.798B 0.00
Baxter (BAX) United States $40.316B 0.00
Terumo (TRUMY) Japan $30.009B 38.36
Zimmer Biomet Holdings (ZBH) United States $27.960B 23.20
EssilorLuxottica Societe Anonyme (ESLOY) France $27.740B 0.00
ResMed (RMD) United States $24.494B 35.51
Sunny Optical Technology (SNPTF) China $16.508B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.353B 0.00
Bio-Rad Laboratories (BIO) United States $14.962B 67.67
Insulet (PODD) United States $14.703B 622.11
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.255B 43.73
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.174B 10.60
Hill-Rom Holdings (HRC) United States $5.465B 13.56
Canopy Growth (CGC) Canada $5.268B 0.00
Haemonetics (HAE) United States $4.417B 29.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.388B 0.00
Neogen (NEOG) United States $3.998B 65.56
ICU Medical (ICUI) United States $3.904B 29.79
Envista Holdings (NVST) United States $3.806B 25.96
Abcam (ABCZY) $3.251B 0.00
TG Therapeutics (TGTX) United States $3.131B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.118B 0.00
National Vision Holdings (EYE) United States $2.964B 460.63
NuVasive (NUVA) United States $2.522B 35.15
Agios Pharmaceuticals (AGIO) United States $2.380B 0.00
AtriCure (ATRC) United States $1.800B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.692B 0.00
NanoString Technologies (NSTG) United States $1.660B 0.00
Cardiovascular Systems (CSII) United States $1.446B 0.00
MacroGenics (MGNX) United States $1.355B 0.00
Owens & Minor (OMI) United States $1.299B 29.09
Aphria (APHA) Canada $1.221B 0.00
InMode (INMD) Israel $1.154B 29.10
Cerus (CERS) United States $1.010B 0.00
Quanterix (QTRX) United States $0.932B 0.00
PetIQ (PETQ) United States $0.912B 26.16
BioLife Solutions (BLFS) United States $0.840B 437.50
Lantheus Holdings (LNTH) United States $0.815B 11.30
OraSure Technologies (OSUR) United States $0.804B 0.00
Phibro Animal Health (PAHC) United States $0.722B 16.52
Meridian Bioscience (VIVO) United States $0.707B 16.34
LeMaitre Vascular (LMAT) United States $0.687B 41.95
Vapotherm (VAPO) United States $0.642B 0.00
Aurora Cannabis (ACB) Canada $0.583B 0.00
Zynex (ZYXI) United States $0.580B 50.61
Eagle Pharmaceuticals (EGRX) United States $0.566B 80.02
Omeros (OMER) United States $0.551B 0.00
Surmodics (SRDX) United States $0.522B 57.22
VAREX IMAGING (VREX) United States $0.472B 20.46
Viemed Healthcare (VMD) United States $0.341B 12.19
Cytosorbents (CTSO) United States $0.340B 0.00
HEXO (HEXO) $0.318B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.34
Surface Oncology (SURF) United States $0.252B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.241B 0.00
Organigram Holdings (OGI) Canada $0.204B 0.00
Female Health (VERU) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.164B 0.00
Chimerix (CMRX) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.141B 12.46
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Evolus (EOLS) United States $0.130B 0.00
Capricor Therapeutics (CAPR) United States $0.105B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.084B 0.00
Rockwell Medical (RMTI) United States $0.075B 0.00
United-Guardian (UG) United States $0.069B 15.40
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.063B 0.00
Nephros (NEPH) United States $0.058B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.09
ImmuCell (ICCC) United States $0.040B 0.00
FSD PHARMA INC (HUGE) Canada $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Senestech (SNES) United States $0.005B 0.00